Merck Serono seeks first-line use for Erbitux
September 6, 2007Sales and Marketing Erbitux
Merck Serono has seeking a broader licence for its cancer drug Erbitux in Europe to include use as a first-line …
AZ opens clinical pharmacology unit in China
September 6, 2007Research and Development China, em
AstraZeneca has opened its first ever clinical pharmacology unit in China, providing support for more trials to be carried out …
NICE says yes to asthma treatment Xolair
September 6, 2007Sales and Marketing Xolair
Xolair, a drug which helps control the most severe cases of allergic asthma, has been approved for use on the …
European challenge to restrictions on Sutent prescribing
September 6, 2007The European Commission has been asked to intervene in a row over a patient's access to kidney cancer drug Sutent, …
Generic challenger to Eprex approved
September 6, 2007Sales and Marketing
The first ever biosimilar version of blockbuster anaemia drug epoetin alfa has been approved in Europe.The drug is marketed by …
Look who’s talking now
September 3, 2007Medical Communications, Sales and Marketing blog, digi pharma, digital pharma, new media, social networking, technology
The internet loves a good scandal. From compromising celebrity videos to the latest political whisperings, whatever your interest in life, …
Latest news from Datammonitor
August 31, 2007Sales and Marketing
Advanced Life Sciences metastatic melanoma drug granted orphan statusThe FDA has granted orphan drug designation to Advanced Life Sciences for …
GSK’s orphan drug for leukaemia approved
August 30, 2007Sales and Marketing
Atriance, a new treatment for two rare, but deadly, types of blood cancer has been approved in Europe as an …
New blood pressure drug Rasilez approved in Europe
August 30, 2007Sales and Marketing
New high blood pressure medication Rasilez has been approved in Europe, with its marketers Novartis claiming it is the first …
Efficient NHS will stay out of debt, says Johnson
August 30, 2007Health secretary Alan Johnson has confidently predicted that the NHS will not slip back into debt this year – and …
New Rebif formulation approved in Europe
August 30, 2007Sales and Marketing
A new version of multiple sclerosis treatment Rebif, which promises to produce fewer reactions when patients inject it, is to …
Pfizer and BMS to fight fat together
August 29, 2007Research and Development
A new research collaboration between Pfizer and Bristol-Myers Squibb could eventually produce innovative treatments for metabolic diseases including obesity and …
Latest news from Datamonitor
August 28, 2007Research and Development, Sales and Marketing
Alfacell reports promising results for cancer drugAlfacell Corporation has reported the results of a preclinical study showing that its cancer …
The interim: a new kind of manager
August 28, 2007Business Services careers, interim management, recruitment
Interim management has been around since the 1980s, but it has come a long way since then. Twenty years ago, …
Avastin approved as first-line treatment for lung cancer
August 24, 2007Sales and Marketing avastin, lung cancer
Roche's cancer drug Avastin has gained European approval as a first-line treatment for lung cancer on the back of data …
Tysabri wins NICE approval
August 23, 2007Sales and Marketing
NICE has approved Biogen Idec's Tysabri for rapidly evolving severe relapsing/remitting multiple sclerosis (RRMS), using its fast-track, single technology appraisal …
Pfizer appoints new finance chief
August 23, 2007Sales and Marketing Pfizer
Pfizer has appointed Frank D'Amelio as its new head of finance, and says he has a strong track record in …
Patient information high on MHRA agenda
August 22, 2007Medical Communications patients
The MHRA has launched a wide-ranging consultation on its future direction, and improving information for patients is a key topic …
Improve services or lose out to private sector, government warns GPs
August 21, 2007The Department of Health has sent out a strongly-worded warning to England's GPs, telling them they must open in evenings …
Roche unveils Pegasys compliance service
August 21, 2007Medical Communications compliance, patients
Roche has set up a new multimedia service to support patients prescribed its hepatitis C treatment, Pegasys.Roche has been a …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
